85 related articles for article (PubMed ID: 22276463)
21. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
[TBL] [Abstract][Full Text] [Related]
22. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
Fang MC; Stafford RS; Ruskin JN; Singer DE
Arch Intern Med; 2004 Jan; 164(1):55-60. PubMed ID: 14718322
[TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin-acenocoumarol interaction.
Mondillo S; Ballo P; Galderisi M
Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
Abdelhafiz AH; Wheeldon NM
Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
[TBL] [Abstract][Full Text] [Related]
25. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
[TBL] [Abstract][Full Text] [Related]
26. Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery.
Cagli K; Ozeke O; Ergun K; Budak B; Demirtas E; Birincioglu CL; Pac M
J Card Surg; 2006; 21(5):458-64. PubMed ID: 16948756
[TBL] [Abstract][Full Text] [Related]
27. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
28. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
29. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
30. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
Lip GY
Am J Med; 2011 Feb; 124(2):111-4. PubMed ID: 20887966
[TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulant therapy for heart disease: results in actual cardiology practice.
Baggio D; Madore F; Lalonde G
Can J Cardiol; 2000 Feb; 16(2):153-61. PubMed ID: 10694585
[TBL] [Abstract][Full Text] [Related]
32. Analysis and occurrence of adverse events with oral anticoagulant therapy.
Schenk JF; Mörsdorf S; Pindur G; Munter KH; Thrun F; Tiaden JD; Wenzel E
Semin Thromb Hemost; 1999; 25(1):65-71. PubMed ID: 10327223
[TBL] [Abstract][Full Text] [Related]
33. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
34. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
Kerin NZ; Faitel K; Naini M
Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
38. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?
Stead LG; Jain A; Bellolio MF; Odufuye AO; Dhillon RK; Manivannan V; Gilmore RM; Rabinstein AA; Chandra R; Serrano LA; Yerragondu N; Palamari B; Decker WW
Clin Neurol Neurosurg; 2010 May; 112(4):275-81. PubMed ID: 20042270
[TBL] [Abstract][Full Text] [Related]
39. Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
Bharat V; Mohanty B
J Assoc Physicians India; 2000 Jul; 48(7):746-7. PubMed ID: 11273517
[TBL] [Abstract][Full Text] [Related]
40. Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.
Lam J; Gomes T; Juurlink DN; Mamdani MM; Pullenayegum EM; Kearon C; Spencer FA; Paterson M; Zheng H; Holbrook AM
Am J Cardiol; 2013 Aug; 112(3):420-3. PubMed ID: 23664078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]